Fenglin Cai
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Gastric Cancer Management and Outcomes
- Metastasis and carcinoma case studies
Papers in
-
- Epigenetics and DNA Methylation 5
- Cancer-related gene regulation 5
- RNA modifications and cancer 4
-
- Gastric Cancer Management and Outcomes 7
- Metastasis and carcinoma case studies 6
- Co-authors
- Jinhai Tang (3 shared papers)Jingyu Deng (15 shared papers)Rupeng Zhang (12 shared papers)Gang Ma (9 shared papers)Gang Ye (1 shared paper)Pengliang Wang (7 shared papers)Lei Tang (1 shared paper)Deyuan Fu (2 shared papers)
- Journals
- Cell Death and Disease (3 papers)Clinical Epigenetics (2 papers)Surgery (2 papers)Experimental Cell Research (2 papers)British Journal of Cancer (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Fenglin Cai
23 papers receiving 266 citations
Peers
Comparison fields: 5 of 58
- Cancer Research 101
- Pulmonary and Respiratory Medicine 81
- Molecular Biology 159
- Oncology 57
- Pharmacology 7
Countries citing papers authored by Fenglin Cai
This map shows the geographic impact of Fenglin Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fenglin Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fenglin Cai more than expected).
Fields of papers citing papers by Fenglin Cai
This network shows the impact of papers produced by Fenglin Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fenglin Cai. The network helps show where Fenglin Cai may publish in the future.
Co-authors
The 25 scholars most cited alongside Fenglin Cai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 40 | |
| 2 | 2020 | 40 | |
| 3 | 2015 | 26 | |
| 4 | 2021 | 22 | |
| 5 | 2015 | 21 | |
| 6 | 2019 | 20 | |
| 7 | 2022 | 14 | |
| 8 | 2021 | 13 | |
| 9 | 2023 | 12 | |
| 10 | 2023 | 10 | |
| 11 | 2024 | 9 | |
| 12 | 2023 | 9 | |
| 13 | 2023 | 7 | |
| 14 | 2019 | 5 | |
| 15 | 2024 | 4 | |
| 16 | 2024 | 3 | |
| 17 | 2024 | 3 | |
| 18 | 2023 | 3 | |
| 19 | 2024 | 3 | |
| 20 | 2021 | 2 |
About Fenglin Cai
Fenglin Cai is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Surgery, Cancer Research and Oncology, having authored 25 papers that have together received 269 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (7 papers), Metastasis and carcinoma case studies (6 papers), Epigenetics and DNA Methylation (5 papers), Cancer-related gene regulation (5 papers), RNA modifications and cancer (4 papers), Helicobacter pylori-related gastroenterology studies (3 papers), MicroRNA in disease regulation (2 papers) and Gastrointestinal Tumor Research and Treatment (2 papers). The work is most often cited by research in Cancer Research (101 citations), Pulmonary and Respiratory Medicine (81 citations), Molecular Biology (159 citations), Oncology (57 citations) and Pharmacology (7 citations). Fenglin Cai has collaborated with scholars based in China and United States. Frequent co-authors include Jinhai Tang, Jingyu Deng, Rupeng Zhang, Gang Ma, Gang Ye, Pengliang Wang, Lei Tang, Deyuan Fu, Han Liang and Ping Chen. Their work appears in journals such as Cell Death and Disease, Clinical Epigenetics, Surgery, Experimental Cell Research and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.